Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.

PLoS One · 2014 · PMC3916324 · PMID 24516537

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a small trendno p-value reported

The results were quite similar to those first presented in the literature despite a small trend toward an improved disease control rate (48.9%), PFS (8 months) and OS (11 months).

also in 722 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.